Under pressure from Trump, Pfizer agrees to roll back price hikes
Ian Read blinked.
In an unexpected about-face, Pfizer agreed to defer substantial price hikes that went into effect just last week on more than 40 medicines after its chief executive spoke with President Trump, who is under increasing pressure to take action to lower the cost of prescription drugs.